Pub Date : 2024-01-29DOI: 10.1007/s42399-024-01644-y
Abstract
Regarding the preventive treatment of CH, there are few placebo-controlled studies, meaning most treatment recommendations by physicians are limited to results from open observational studies. Additionally, existing effective therapies are believed to be underused because of our underdiagnosis of CH syndrome. Numerous treatment methods are available for different CH attack stages, making them difficult to manage. Some treatment options include inhalation of 100% oxygen or subcutaneous/intranasal administration of sumatriptan for acute cluster attacks and bridging therapy with oral prednisolone until oral prophylactic therapy is effective. Finally, drugs for the preventive treatment of CH include verapamil, lithium, divalproex sodium (Depakote), gabapentin, and topiramate. Patients suffering from CH should first be encouraged to change potentially harmful lifestyle activities, including smoking or alcohol consumption, especially during cluster periods, to minimize CH episodes as much as possible before initiating acute or prophylactic drug treatment. Cluster headaches (CH) are categorized under trigeminal autonomic headaches. CH is generally treated through acute drug therapy and preventive medicine. These excruciating, unilateral headaches are usually accompanied by conjunctival injections and lacrimation, which involve bursts of moderate to severe burning, piercing, or throbbing pain and occur acutely, episodically, or chronically. Increasing controversy continues to challenge research on CH, especially prophylactic treatment, related to the intensities of CH pain and increased ethical concerns surrounding placebo treatments, making the design of randomized controlled trials difficult. Fortunately, as new technologies and genetic studies emerge, researchers better understand the etiology of CH, allowing for more specific targeted therapies. Therefore, this review discusses divalproex, valproate, and other traditional and novel prophylactic treatment options for CH, comparing their safety profiles, pharmacodynamics, pharmacokinetics, and limitations.
{"title":"Divalproex, Valproate, & Developing Treatment Options for Cluster Headache Prophylaxis: Clinical Practice Considerations","authors":"","doi":"10.1007/s42399-024-01644-y","DOIUrl":"https://doi.org/10.1007/s42399-024-01644-y","url":null,"abstract":"<h3>Abstract</h3> <p>Regarding the preventive treatment of CH, there are few placebo-controlled studies, meaning most treatment recommendations by physicians are limited to results from open observational studies. Additionally, existing effective therapies are believed to be underused because of our underdiagnosis of CH syndrome. Numerous treatment methods are available for different CH attack stages, making them difficult to manage. Some treatment options include inhalation of 100% oxygen or subcutaneous/intranasal administration of sumatriptan for acute cluster attacks and bridging therapy with oral prednisolone until oral prophylactic therapy is effective. Finally, drugs for the preventive treatment of CH include verapamil, lithium, divalproex sodium (Depakote), gabapentin, and topiramate. Patients suffering from CH should first be encouraged to change potentially harmful lifestyle activities, including smoking or alcohol consumption, especially during cluster periods, to minimize CH episodes as much as possible before initiating acute or prophylactic drug treatment. Cluster headaches (CH) are categorized under trigeminal autonomic headaches. CH is generally treated through acute drug therapy and preventive medicine. These excruciating, unilateral headaches are usually accompanied by conjunctival injections and lacrimation, which involve bursts of moderate to severe burning, piercing, or throbbing pain and occur acutely, episodically, or chronically. Increasing controversy continues to challenge research on CH, especially prophylactic treatment, related to the intensities of CH pain and increased ethical concerns surrounding placebo treatments, making the design of randomized controlled trials difficult. Fortunately, as new technologies and genetic studies emerge, researchers better understand the etiology of CH, allowing for more specific targeted therapies. Therefore, this review discusses divalproex, valproate, and other traditional and novel prophylactic treatment options for CH, comparing their safety profiles, pharmacodynamics, pharmacokinetics, and limitations.</p>","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"227 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139589423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-26DOI: 10.1007/s42399-024-01645-x
Abstract
Ultrasound has become a valuable tool for detecting fluid accumulations due to its ability to reveal the nature of the fluid based on its appearance and anatomical location. This case report explores the use of ultrasound in diagnosing an abdominal collection suggestive of peritonitis by introducing an ultrasonographic dynamic sign. A 37-year-old patient, post-rectal tumor surgery, presented with abdominal pain, peritoneal reaction, and clinical deterioration necessitating intensive care. Point-of-care ultrasound revealed a hyperechoic, mobile, image with septa resembling a jellyfish in the subhepatic region, indicating a complicated fluid collection. Abdominal CT confirmed the presence of free fluid in perihepatic and left subphrenic regions. Subsequent surgery revealed peritonitis, anastomosis suture dehiscence, and successful management in the ICU. Recognizing the “abdominal jellyfish sign” and interpreting it appropriately within the relevant clinical context aids in the diagnosis of complicated abdominal collections. Further studies employing alternative methodologies will be necessary to confirm or refute the true significance of this sign in this context.
{"title":"The Abdominal Jellyfish Sign: An Ultrasonographic Approach for Diagnosing Abdominal Collections — A Case Report","authors":"","doi":"10.1007/s42399-024-01645-x","DOIUrl":"https://doi.org/10.1007/s42399-024-01645-x","url":null,"abstract":"<h3>Abstract</h3> <p>Ultrasound has become a valuable tool for detecting fluid accumulations due to its ability to reveal the nature of the fluid based on its appearance and anatomical location. This case report explores the use of ultrasound in diagnosing an abdominal collection suggestive of peritonitis by introducing an ultrasonographic dynamic sign. A 37-year-old patient, post-rectal tumor surgery, presented with abdominal pain, peritoneal reaction, and clinical deterioration necessitating intensive care. Point-of-care ultrasound revealed a hyperechoic, mobile, image with septa resembling a jellyfish in the subhepatic region, indicating a complicated fluid collection. Abdominal CT confirmed the presence of free fluid in perihepatic and left subphrenic regions. Subsequent surgery revealed peritonitis, anastomosis suture dehiscence, and successful management in the ICU. Recognizing the “abdominal jellyfish sign” and interpreting it appropriately within the relevant clinical context aids in the diagnosis of complicated abdominal collections. Further studies employing alternative methodologies will be necessary to confirm or refute the true significance of this sign in this context.</p>","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"398 2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139589365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-19DOI: 10.1007/s42399-024-01643-z
Abstract
Antiphospholipid antibody syndrome (APS) is an acquired thrombophilia with multisystem involvement. This study was undertaken to study the antibody profile of pregnant women with APS and their pregnancy outcomes. This retrospective study was conducted in a tertiary care teaching institute in Southern India. Data of 231 APS-positive pregnancies in 104 women were analyzed in this study. The primary outcome was to study the adverse outcomes such as abortions, intrauterine fetal death, neonatal death, maternal thrombotic events, and preeclampsia in APS-complicated pregnancies. Secondary outcomes were to study the adverse clinical outcomes in comparison to various antiphospholipid antibodies; primary versus secondary APS; and obstetric versus thrombotic APS. Anticardiolipin antibody (ACLA) (n = 157, 68%) was the most common antibody identified followed by lupus anticoagulant (LA) (n = 80, 34.6%) and beta-2-glycoprotein (B2GP) (n = 48, 20.8%). B2GP positivity was associated with higher fetal growth restriction (FGR) (66.7% vs 36.3% vs 32.6%, p value 0.05) and stillbirth (30% vs 9.5% vs 13%, p 0.004) in comparison to ACLA and LA. Multiple antibody positivity was associated with a significantly higher first trimester losses (55.2% first trimester loss in double positive versus 43.2% in single antibody positive group; p 0.004). Thrombotic APS was associated with higher rates of intrauterine growth–restricted fetuses than obstetric APS (35.2% vs 55.9%, p 0.032). ACLA is the most common antibody identified in the APS-positive pregnancies in Southern Indian population. The adverse pregnancy outcomes were higher in multiple antibody positivity and B2GP group.
{"title":"Pregnancy and Clinical Outcome Among Women with Antiphospholipid Antibody Syndrome—A Tertiary Care Center–Based Observational Study","authors":"","doi":"10.1007/s42399-024-01643-z","DOIUrl":"https://doi.org/10.1007/s42399-024-01643-z","url":null,"abstract":"<h3>Abstract</h3> <p>Antiphospholipid antibody syndrome (APS) is an acquired thrombophilia with multisystem involvement. This study was undertaken to study the antibody profile of pregnant women with APS and their pregnancy outcomes. This retrospective study was conducted in a tertiary care teaching institute in Southern India. Data of 231 APS-positive pregnancies in 104 women were analyzed in this study. The primary outcome was to study the adverse outcomes such as abortions, intrauterine fetal death, neonatal death, maternal thrombotic events, and preeclampsia in APS-complicated pregnancies. Secondary outcomes were to study the adverse clinical outcomes in comparison to various antiphospholipid antibodies; primary versus secondary APS; and obstetric versus thrombotic APS. Anticardiolipin antibody (ACLA) (<em>n</em> = 157, 68%) was the most common antibody identified followed by lupus anticoagulant (LA) (<em>n</em> = 80, 34.6%) and beta-2-glycoprotein (B2GP) (<em>n</em> = 48, 20.8%). B2GP positivity was associated with higher fetal growth restriction (FGR) (66.7% vs 36.3% vs 32.6%, <em>p</em> value 0.05) and stillbirth (30% vs 9.5% vs 13%, <em>p</em> 0.004) in comparison to ACLA and LA. Multiple antibody positivity was associated with a significantly higher first trimester losses (55.2% first trimester loss in double positive versus 43.2% in single antibody positive group; <em>p</em> 0.004). Thrombotic APS was associated with higher rates of intrauterine growth–restricted fetuses than obstetric APS (35.2% vs 55.9%, <em>p</em> 0.032). ACLA is the most common antibody identified in the APS-positive pregnancies in Southern Indian population. The adverse pregnancy outcomes were higher in multiple antibody positivity and B2GP group.</p>","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139507974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-18DOI: 10.1007/s42399-024-01641-1
Atefeh Ghanbari Jolfaei, Razieh Salehian, Mohammad Pirhayati
Obesity can affect physical and mental health, as well as quality of life. It is necessary to pay attention to it and its treatment methods. One of the current treatments for morbid obesity is bariatric surgery. Since obesity affects the mental health of people and the mental health of people affects the development of obesity and the consequences and progress of its treatment, the purpose of this article is to investigate the prevalence of mood disorders in applicants for bariatric surgery. A cross-sectional study was conducted on 250 obese patients who were candidates for bariatric surgery and 100 of their normal weight relatives. Questionnaires BSDS, MDQ, and demographic questionnaire were used, and those who showed signs of bipolar disorder were further evaluated through SCID-5. Regarding gender, 24.4% of the total number of obese patients studied were male and 75.6% were female. Twenty-two percent of obese patients suffered from bipolar disorder. Among people with bipolar spectrum disorders, 21.8% had bipolar disorder I, 9.1% had bipolar disorder II, 50.9% had bipolar disorder NOS, and 18.8% had cyclothymia. In the control group, 11 patients (11%) had bipolar disorder, non-obese individuals had significantly lower values compared to obese individuals (p = 0.001), 4 patients (4%) had bipolar disorder type II, and 7 (7%) had bipolar disorder NOS. The prevalence of bipolar spectrum disorders was almost twice that of the control group, indicating the importance of screening for these disorders in patients with obesity.
肥胖会影响身心健康和生活质量。我们有必要关注肥胖症及其治疗方法。减肥手术是目前治疗病态肥胖症的方法之一。由于肥胖会影响人的心理健康,而人的心理健康又会影响肥胖的发展及其治疗的后果和进展,因此本文旨在调查减肥手术申请者中情绪障碍的发生率。一项横断面研究针对 250 名申请减肥手术的肥胖患者及其 100 名体重正常的亲属展开。研究使用了BSDS、MDQ和人口学问卷,并通过SCID-5对有双相情感障碍迹象的患者进行了进一步评估。在性别方面,24.4%的肥胖患者为男性,75.6%为女性。22%的肥胖患者患有躁郁症。在躁郁症谱系障碍患者中,21.8%患有躁郁症 I,9.1%患有躁郁症 II,50.9%患有躁郁症 NOS,18.8%患有周期性躁郁症。在对照组中,11 名患者(11%)患有双相情感障碍,非肥胖者的数值明显低于肥胖者(P = 0.001),4 名患者(4%)患有双相情感障碍 II 型,7 名患者(7%)患有双相情感障碍 NOS 型。躁郁症谱系障碍的患病率几乎是对照组的两倍,这表明对肥胖症患者进行躁郁症谱系障碍筛查的重要性。
{"title":"Comparing the Prevalence of Bipolar Disorders in Bariatric Surgery Candidates with a Control Group: A Cross-Sectional Study","authors":"Atefeh Ghanbari Jolfaei, Razieh Salehian, Mohammad Pirhayati","doi":"10.1007/s42399-024-01641-1","DOIUrl":"https://doi.org/10.1007/s42399-024-01641-1","url":null,"abstract":"<p>Obesity can affect physical and mental health, as well as quality of life. It is necessary to pay attention to it and its treatment methods. One of the current treatments for morbid obesity is bariatric surgery. Since obesity affects the mental health of people and the mental health of people affects the development of obesity and the consequences and progress of its treatment, the purpose of this article is to investigate the prevalence of mood disorders in applicants for bariatric surgery. A cross-sectional study was conducted on 250 obese patients who were candidates for bariatric surgery and 100 of their normal weight relatives. Questionnaires BSDS, MDQ, and demographic questionnaire were used, and those who showed signs of bipolar disorder were further evaluated through SCID-5. Regarding gender, 24.4% of the total number of obese patients studied were male and 75.6% were female. Twenty-two percent of obese patients suffered from bipolar disorder. Among people with bipolar spectrum disorders, 21.8% had bipolar disorder I, 9.1% had bipolar disorder II, 50.9% had bipolar disorder NOS, and 18.8% had cyclothymia. In the control group, 11 patients (11%) had bipolar disorder, non-obese individuals had significantly lower values compared to obese individuals (<i>p</i> = 0.001), 4 patients (4%) had bipolar disorder type II, and 7 (7%) had bipolar disorder NOS. The prevalence of bipolar spectrum disorders was almost twice that of the control group, indicating the importance of screening for these disorders in patients with obesity.</p>","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139500058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-18DOI: 10.1007/s42399-024-01640-2
M.C. Navas-Aparicio, A. Acuña-Navas, M. Núñez-Delgado
Abstract
The congenital granular cell tumor is a benign soft tissue lesion, unique to the newborn, which originates from the mucosa of the alveolar ridge of the maxillary and mandibular bone in the anterior region. Its diagnosis is made clinically, generally from birth. It is important to learn about this pathology because depending on the size, the tumor can be threatening to the life of the newborn due to mechanical obstruction of the oral cavity, interfering with functions such as swallowing, feeding, proper closure of the oral cavity, and breathing, leading to cyanosis and dyspnea, and being a potential cause of death by asphyxia.
Case Presentation
A 2-day-old girl was in the Neonatology Service, Hospital Nacional de Niños, Caja Costarricense de Seguro Social, for presenting a tumor in the mouth, which was diagnosed by ultrasound in the prenatal period, and for which she was admitted due to possible respiratory distress and clinical deterioration. In her evaluation, a rounded, mobile, fibrous, vascularized lesion of approximately 40 mm × 40 mm was observed, with a wide base adhered to the maxillary alveolar ridge vestibular mucosa. Therefore, it was decided to schedule surgery for excision and biopsy of the tumor. The histopathological study indicated a diagnosis of congenital ulcerated epulis.
Conclusion
The clinical presentation of congenital granular cell tumor, in these case, is impressive due to its size and aggressive appearance, which is important for health professionals to know the characteristics of this benign, rare, and congenital tumor to avoid complications and decide on the procedure to follow.
{"title":"Large Congenital Granular Cell Tumor in the Newborn—Diagnosis and Management: Case Report and Literature Review","authors":"M.C. Navas-Aparicio, A. Acuña-Navas, M. Núñez-Delgado","doi":"10.1007/s42399-024-01640-2","DOIUrl":"https://doi.org/10.1007/s42399-024-01640-2","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Abstract</h3><p>The congenital granular cell tumor is a benign soft tissue lesion, unique to the newborn, which originates from the mucosa of the alveolar ridge of the maxillary and mandibular bone in the anterior region. Its diagnosis is made clinically, generally from birth. It is important to learn about this pathology because depending on the size, the tumor can be threatening to the life of the newborn due to mechanical obstruction of the oral cavity, interfering with functions such as swallowing, feeding, proper closure of the oral cavity, and breathing, leading to cyanosis and dyspnea, and being a potential cause of death by asphyxia.</p><h3 data-test=\"abstract-sub-heading\">Case Presentation</h3><p>A 2-day-old girl was in the Neonatology Service, Hospital Nacional de Niños, Caja Costarricense de Seguro Social, for presenting a tumor in the mouth, which was diagnosed by ultrasound in the prenatal period, and for which she was admitted due to possible respiratory distress and clinical deterioration. In her evaluation, a rounded, mobile, fibrous, vascularized lesion of approximately 40 mm × 40 mm was observed, with a wide base adhered to the maxillary alveolar ridge vestibular mucosa. Therefore, it was decided to schedule surgery for excision and biopsy of the tumor. The histopathological study indicated a diagnosis of congenital ulcerated epulis.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>The clinical presentation of congenital granular cell tumor, in these case, is impressive due to its size and aggressive appearance, which is important for health professionals to know the characteristics of this benign, rare, and congenital tumor to avoid complications and decide on the procedure to follow.</p>","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139499989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-16DOI: 10.1007/s42399-024-01642-0
Hüseyin Tezcan, Zafer Büyükterzi
This study aimed to investigate the preferences of patients who underwent both transradial access (TRA) and transfemoral access for percutaneous coronary interventions (PCIs). The primary focus was on understanding patient preferences and satisfaction with each method to contribute insights into the choice of arterial access in coronary interventions. A single-center prospective study was conducted, including patients who had previously undergone either femoral or radial access for PCI and subsequently chose the alternative access for a second procedure. A comprehensive questionnaire with 13 inquiries was administered to 100 eligible patients, covering aspects such as procedural comfort, pain, embarrassment, and recovery time. The study received ethical approval, and informed consent was obtained from all participants. Among the 100 surveyed patients, all of whom had experienced both TRA and transfemoral access, a unanimous preference for TRA was observed. Patients reported TRA as less stressful, less embarrassing, and less painful both peri- and post-procedurally. Notably, 98% of participants indicated faster recovery and earlier feeding after TRA angiography. No major complications were reported, supporting the safety of TRA. The findings strongly advocate for transradial access as the preferred method for coronary interventions, emphasizing the importance of patient satisfaction in choosing arterial access. The study underscores TRA’s advantages in terms of patient comfort, recovery time, and overall preference, suggesting its incorporation as a routine method for PCI procedures.
本研究旨在调查经桡动脉入路 (TRA) 和经股动脉入路进行经皮冠状动脉介入治疗 (PCI) 的患者的偏好。主要重点是了解患者对每种方法的偏好和满意度,为冠状动脉介入治疗中动脉通路的选择提供见解。我们进行了一项单中心前瞻性研究,研究对象包括曾接受过股动脉或桡动脉介入治疗,并在第二次手术中选择了其他介入方法的患者。研究人员向 100 名符合条件的患者发放了一份包含 13 个问题的综合问卷,内容涉及手术舒适度、疼痛、尴尬和恢复时间等方面。该研究获得了伦理批准,并征得了所有参与者的知情同意。接受调查的 100 名患者均经历过 TRA 和经股动脉入路手术,他们一致倾向于 TRA。患者表示 TRA 在术前和术后的压力较小、尴尬较少、疼痛较轻。值得注意的是,98% 的参与者表示 TRA 血管造影术后恢复更快,进食更早。没有重大并发症的报告,这证明了 TRA 的安全性。研究结果有力地证明了经桡动脉入路是冠状动脉介入治疗的首选方法,强调了患者满意度对选择动脉入路的重要性。研究强调了 TRA 在患者舒适度、恢复时间和总体偏好方面的优势,建议将其作为 PCI 手术的常规方法。
{"title":"Comparative Patient Satisfaction in Coronary Percutaneous Interventions: A Dual Experience with Transradial and Transfemoral Access","authors":"Hüseyin Tezcan, Zafer Büyükterzi","doi":"10.1007/s42399-024-01642-0","DOIUrl":"https://doi.org/10.1007/s42399-024-01642-0","url":null,"abstract":"<p>This study aimed to investigate the preferences of patients who underwent both transradial access (TRA) and transfemoral access for percutaneous coronary interventions (PCIs). The primary focus was on understanding patient preferences and satisfaction with each method to contribute insights into the choice of arterial access in coronary interventions. A single-center prospective study was conducted, including patients who had previously undergone either femoral or radial access for PCI and subsequently chose the alternative access for a second procedure. A comprehensive questionnaire with 13 inquiries was administered to 100 eligible patients, covering aspects such as procedural comfort, pain, embarrassment, and recovery time. The study received ethical approval, and informed consent was obtained from all participants. Among the 100 surveyed patients, all of whom had experienced both TRA and transfemoral access, a unanimous preference for TRA was observed. Patients reported TRA as less stressful, less embarrassing, and less painful both peri- and post-procedurally. Notably, 98% of participants indicated faster recovery and earlier feeding after TRA angiography. No major complications were reported, supporting the safety of TRA. The findings strongly advocate for transradial access as the preferred method for coronary interventions, emphasizing the importance of patient satisfaction in choosing arterial access. The study underscores TRA’s advantages in terms of patient comfort, recovery time, and overall preference, suggesting its incorporation as a routine method for PCI procedures.</p>","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139474953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-13DOI: 10.1007/s42399-023-01636-4
Marek M. Rogowski, Kaffer Kara
{"title":"Late In-Stent Restenosis of a Saphenous Vein Graft Treated with High-Pressure Balloon Dilatation and Drug Eluting Balloon Dilatation: Case Report","authors":"Marek M. Rogowski, Kaffer Kara","doi":"10.1007/s42399-023-01636-4","DOIUrl":"https://doi.org/10.1007/s42399-023-01636-4","url":null,"abstract":"","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"16 12","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139437242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-13DOI: 10.1007/s42399-024-01639-9
T. Ishikawa, T. Masuda, H. Ikenaga, Hiroyasu Sanai, R. Moriwake, D. Yao, Koji Yoshida, Atsushi Ono, Junichi Hiratsuka, Tsutomu Tamada
{"title":"Effect of Patient Characteristics, Including Cardiothoracic Ratio, on Vessel Enhancement in Coronary Computed Tomography Angiography","authors":"T. Ishikawa, T. Masuda, H. Ikenaga, Hiroyasu Sanai, R. Moriwake, D. Yao, Koji Yoshida, Atsushi Ono, Junichi Hiratsuka, Tsutomu Tamada","doi":"10.1007/s42399-024-01639-9","DOIUrl":"https://doi.org/10.1007/s42399-024-01639-9","url":null,"abstract":"","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"21 7","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139437148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-10DOI: 10.1007/s42399-023-01637-3
Marco Pace, Marco Moretti, Simone Maria Tierno, Alessandro Dario Mazzotta, Andrea Felice Ferroni, Marco Di Giovan Paolo, Valeria Gianfreda, Salvatore Bianca, Apostolos Barbarosos, Carlo Eugenio Vitelli, Michelangelo Boninfante, Francesco Stipa
Leiomyomas are benign tumors, mostly located in the uterus. The pelvic localization is quite rare, and it is associated with unusual growth patterns. It is important to make an adequate differential diagnosis between malignant and benign retroperitoneal neoplasm because treatment is different. When it is not possible to have a precise preoperative diagnosis, a laparoscopic or laparotomy surgical tumorectomy is often required. To obtain a certain diagnosis, the goal of surgery is ensuring the complete excision of neoplasms and preservation of urination, defecation, and sexual function. We report a rare case of a 58-year-old woman who underwent a laparoscopic tumorectomy for a pelvic retroperitoneal leiomyoma. The patient reported occasional episodes of dull pain in the pelvic region. Pelvic contrast CT scan and magnetic resonance imaging (MRI) showed a retroperitoneal solid mass in contiguity with the posterior wall of the uterine body-isthmus, to be referred to as a pedunculated uterine fibroma strictly posteriorly adherent to the sigma. She first underwent to explorative laparoscopy by a gynecologist who did not find any uterine mass. The patient was subsequently admitted to the department of general surgery and has done a second operative laparoscopy which highlighted the presence of an extra-peritoneal para-rectal mass which was completely excised. The histological examination of tumor indicated that it was a leiomyoma. The postoperative course was uneventful, and the patient was discharged in III post-operative day (POD).
{"title":"Laparoscopic Tumorectomy for an Unusual Pelvic Retroperitoneal Leiomyoma: A Case Report","authors":"Marco Pace, Marco Moretti, Simone Maria Tierno, Alessandro Dario Mazzotta, Andrea Felice Ferroni, Marco Di Giovan Paolo, Valeria Gianfreda, Salvatore Bianca, Apostolos Barbarosos, Carlo Eugenio Vitelli, Michelangelo Boninfante, Francesco Stipa","doi":"10.1007/s42399-023-01637-3","DOIUrl":"https://doi.org/10.1007/s42399-023-01637-3","url":null,"abstract":"<p>Leiomyomas are benign tumors, mostly located in the uterus. The pelvic localization is quite rare, and it is associated with unusual growth patterns. It is important to make an adequate differential diagnosis between malignant and benign retroperitoneal neoplasm because treatment is different. When it is not possible to have a precise preoperative diagnosis, a laparoscopic or laparotomy surgical tumorectomy is often required. To obtain a certain diagnosis, the goal of surgery is ensuring the complete excision of neoplasms and preservation of urination, defecation, and sexual function. We report a rare case of a 58-year-old woman who underwent a laparoscopic tumorectomy for a pelvic retroperitoneal leiomyoma. The patient reported occasional episodes of dull pain in the pelvic region. Pelvic contrast CT scan and magnetic resonance imaging (MRI) showed a retroperitoneal solid mass in contiguity with the posterior wall of the uterine body-isthmus, to be referred to as a pedunculated uterine fibroma strictly posteriorly adherent to the sigma. She first underwent to explorative laparoscopy by a gynecologist who did not find any uterine mass. The patient was subsequently admitted to the department of general surgery and has done a second operative laparoscopy which highlighted the presence of an extra-peritoneal para-rectal mass which was completely excised. The histological examination of tumor indicated that it was a leiomyoma. The postoperative course was uneventful, and the patient was discharged in III post-operative day (POD).</p>","PeriodicalId":21944,"journal":{"name":"SN Comprehensive Clinical Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139409389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}